1. Westermark P, Benson MD, Buxbaum JN, et al. Amyloid fibril protein nomenclature - 2002. Amyloid. 2002; 9:197–200.
Article
2. Lee HM, Naor J, DeAngelis D, Rootman DS. Primary localized conjunctival amyloidosis presenting with recurrence of subconjunctival hemorrhage. Am J Ophthalmol. 2000; 129:245–7.
Article
3. Moorman CM, McDonald B. Primary (localised non-familial) conjunctival amyloidosis: three case reports. Eye (Lond). 1997; 11:603–6.
Article
4. Demirci H, Shields CL, Eagle RC Jr, Shields JA. Conjunctival amyloidosis: report of six cases and review of the literature. Surv Ophthalmol. 2006; 51:419–33.
Article
5. Fraunfelder FW. Liquid nitrogen cryotherapy for conjunctival amyloidosis. Arch Ophthalmol. 2009; 127:645–8.
Article
6. Rosenblatt M, Spitz GF, Friedman AH, Kazam ES. Localized conjunctival amyloidosis: case reports and review of literature. Ophthalmologica. 1986; 192:238–45.
Article
7. Merlini G, Westermark P. The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies. J Intern Med. 2004; 255:159–78.
Article
8. Gertz MA, Lacy MQ, Dispenzieri A. Amyloidosis. Hematol Oncol Clin North Am. 1999; 13:1211–33.
Article
9. Leibovitch I, Selva D, Goldberg RA, et al. Periocular and orbital amyloidosis: clinical characteristics, management, and outcome. Ophthalmology. 2006; 113:1657–64.
10. Pepys MB. Amyloidosis. Annu Rev Med. 2006; 57:223–41.
Article
11. Eichler MD, Fraunfelder FT. Cryotherapy for conjunctival lym-phoid tumors. Am J Ophthalmol. 1994; 118:463–7.
Article
12. Hazenberg BP, van Gameren II, Bijzet J, et al. Diagnostic and therapeutic approach of systemic amyloidosis. Neth J Med. 2004; 62:121–8.
13. Song BR, Kim YK, Yoo JH, Chu YC. Primary localized amyloidosis of bulbar conjunctiva and cornea. J Korean Ophthalmol Soc. 1993; 34:352–6.